Allist(SH:688578) Xin Lang Cai Jing·2025-09-24 11:08Core Points - Shanghai Ailis Pharmaceutical Technology Co., Ltd. announced the results of shareholder share reduction, revealing the reduction situation of employee shareholding platforms [1] Group 1: Shareholding Situation Before Reduction - Before the reduction plan, Shanghai Aixiang held 32,930,660 shares, accounting for 7.32% of the total share capital; Nantong Aiyun held 9,770,362 shares, accounting for 2.17% of the total share capital [2] Group 2: Review of Reduction Plan - On August 9, 2025, Ailis disclosed a share reduction plan, intending to reduce a total of no more than 13,500,000 shares, accounting for no more than 3.00% of the total share capital, through block trading and centralized bidding from September 1, 2025, within three months [3] Group 3: Results of Share Reduction - As of September 24, 2025, the two shareholding platforms had cumulatively reduced 13,500,000 shares, achieving the planned reduction of 3.00% of the total share capital. Specifically, Shanghai Aixiang reduced 10,410,000 shares (2.31%) and Nantong Aiyun reduced 3,090,000 shares (0.69%). The reduction price ranged from 100.00 to 115.35 yuan per share, with total amounts of 1,114,190,265.82 yuan and 330,436,753.50 yuan respectively [4]